Elekta: Leksell Gamma Knife® Perfexion? Receives Regulatory Approval in Japan

Regulatory News: The Japanese Ministry for Health, Labor and Welfare, MHLW, has given

approval for Leksell Gamma Knife® Perfexionâ„¢

the world-leading clinical solution for non-invasive radiosurgical

treatments of tumors, vascular malformations and other brain disorders.

Elekta, the international medical technology group and developer of

Gamma Knife® surgery, will now be able to

deliver and install this advanced technology at new and existing

customer sites in Japan. Gamma Knife surgery has become the world´s

most widely used radiosurgery treatment due to its extraordinary

accuracy, reduction of excess radiation dose to the body, extensive

history and clinical documentation. Unlike other systems, invoking

compromises in order to be able to treat the whole body, Leksell Gamma

Knife is specifically designed to optimize treatment to the head and

neck area "“ a fact appreciated by

neurosurgeons and patients alike. Launched by Elekta in 2006 and now in clinical use in over 30 locations

around the world, Leksell Gamma Knife Perfexion combines the proven

precision of the revolutionary Leksell Gamma Knife, with a dramatic

increase in clinical reach to treat a wider range of targets faster and

more efficiently than ever before. The system´s

unique geometric and dosimetric design robotically administers thousands

of beams of low-intensity radiation that converge to deliver a single

therapeutic dose of radiation with pin-point accuracy to the most

difficult targets; while integrated treatment planning and delivery

streamlines the radiosurgery process to treat even multiple brain

lesions in a single automated procedure. Over 50 centers in Japan are currently offering Gamma Knife surgery to

patients with benign or malignant brain tumors, vascular malformations

and certain functional brain disorders. Several of these have already

expressed interest in upgrading their facility to Leksell Gamma Knife

Perfexion. At the recent International Leksell Gamma Knife® Society Meeting on May 18-22, in Quebec, Canada, a large number of

Japanese neurosurgeons and other clinicians attended and was presented

with clinical data from the current users of Leksell Gamma Knife

Perfexion. About Elekta Elekta is an international medical technology group, providing

oncologists, radiation therapists, neurosurgeons and many other medical

specialists with state of the art tools to fight serious disease. Elekta provides advanced clinical solutions, comprehensive management

and information systems as well as services for improved cancer care and

management of brain disorders. Elekta´s systems and solutions are used in

over 5,000 hospitals around the world. Clinical and information

management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesseâ„¢ and Elekta Synergy® for stereotactic and image

guided radiation therapy and radiosurgery as well as the MOSAIQâ„¢ suite of software for image-enabled EMR and efficient management of

clinical and patient data. With over 2,500 employees globally, the corporate headquarter is located

in Stockholm, Sweden and the company is listed on the Nordic Exchange

under the ticker EKTAb. More information about Elekta can be found at www.elekta.com. This information was brought to you by Cision http://newsroom.cision.com